Technical Analysis for CBMG - Cellular Biomedicine Group, Inc.

Grade Last Price % Change Price Change
grade C 14.93 2.97% 0.43
CBMG closed up 2.97 percent on Thursday, October 17, 2019, on 31 percent of normal volume.

Earnings due: Nov 4

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical CBMG trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Fell Below 20 DMA Bearish 2.97%
20 DMA Support Bullish -2.23%
Pocket Pivot Bullish Swing Setup -2.23%
20 DMA Support Bullish 1.01%
Narrow Range Bar Range Contraction 1.01%
NR7 Range Contraction 1.01%
Inside Day Range Contraction 1.01%

Older signals for CBMG ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Cellular Biomedicine Group Inc., a biomedicine company, engages in the development of treatments for cancerous and degenerative diseases in Greater China. The company focuses on developing and marketing cell-based therapeutic products to treat serious chronic and degenerative diseases, including cancer, osteoarthritis, tissue damage, spinal muscular atrophy, various inflammatory diseases, and joint diseases. It is developing treatments utilizing proprietary cell technologies, which include tumor cell specific dendritic cells for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint disease; human umbilical cord-derived mesenchymal progenitor cells; human embryo-derived motor neuron progenitor precursor cells; and human embryo-derived neuronal progenitor precursor cells for the treatment of central nervous system diseases. The company is headquartered in Palo Alto, California.
Cancer Life Sciences Biology Cancers Stem Cells Tumor Osteoarthritis Inflammatory Diseases Spinal Muscular Atrophy Stem Cell Therapy Central Nervous System Diseases Degenerative Disease Treatment Of Central Nervous System Diseases Mesenchymal Stem Cell
Is CBMG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.63
52 Week Low 10.98
Average Volume 31,783
200-Day Moving Average 15.8557
50-Day Moving Average 13.516
20-Day Moving Average 14.6565
10-Day Moving Average 14.607
Average True Range 0.6696
ADX 16.81
+DI 21.1566
-DI 15.9144
Chandelier Exit (Long, 3 ATRs ) 13.6112
Chandelier Exit (Short, 3 ATRs ) 15.7888
Upper Bollinger Band 15.4369
Lower Bollinger Band 13.8761
Percent B (%b) 0.68
BandWidth 10.6492
MACD Line 0.2805
MACD Signal Line 0.3253
MACD Histogram -0.0448
Fundamentals Value
Market Cap 210.64 Million
Num Shares 14.1 Million
EPS -2.06
Price-to-Earnings (P/E) Ratio -7.25
Price-to-Sales 587.89
Price-to-Book 2.44
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.55
Resistance 3 (R3) 15.50 15.24 15.44
Resistance 2 (R2) 15.24 15.09 15.27 15.41
Resistance 1 (R1) 15.09 14.99 15.17 15.14 15.37
Pivot Point 14.83 14.83 14.87 14.86 14.83
Support 1 (S1) 14.68 14.68 14.76 14.73 14.49
Support 2 (S2) 14.42 14.58 14.45 14.45
Support 3 (S3) 14.27 14.42 14.42
Support 4 (S4) 14.32